CRMD

SEC source: 0001213900-25-003532 · ownership.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,728

SEC source: 0001213900-25-001355 · ownership.xml · nonDerivative · entry 2

Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,612

SEC source: 0001213900-25-001355 · ownership.xml · nonDerivative · entry 1

Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,456

F1 · price: These shares represent restricted stock units granted on 01/02/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0001213900-25-001356 · ownership.xml · nonDerivative · entry 2

David Matthew T · CIK 0001811612 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,786

SEC source: 0001213900-25-001356 · ownership.xml · nonDerivative · entry 1

David Matthew T · CIK 0001811612 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,434

F1 · price: These shares represent restricted stock units granted on 01/02/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0001213900-25-001358 · ownership.xml · nonDerivative · entry 2

Mistry Erin · CIK 0001962774 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,681

SEC source: 0001213900-25-001358 · ownership.xml · nonDerivative · entry 1

Mistry Erin · CIK 0001962774 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,511

F1 · price: These shares represent restricted stock units granted on 01/02/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0001213900-25-001357 · ownership.xml · nonDerivative · entry 2

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,519

SEC source: 0001213900-25-001357 · ownership.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,897

F1 · price: These shares represent restricted stock units granted on 01/02/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000899140-24-001355 · form4.xml · derivative · entry 3

Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 12,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Restricted Stock Units were granted on 12/12/2023 and vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.

F2 · derivative.expiration_date: These Restricted Stock Units were granted on 12/12/2023 and vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.

SEC source: 0000899140-24-001355 · form4.xml · nonDerivative · entry 2

Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,456

SEC source: 0000899140-24-001355 · form4.xml · nonDerivative · entry 1

Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0000899140-24-001360 · form4.xml · nonDerivative · entry 1

Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,956

F1 · balance_after: The reporting person has filed this amendment to restate the transaction reported in the Form 4 filed December 16, 2024 in order to correct the amount of Common Stock beneficially owned by the reporting person following the transaction and to remove a duplicative reference to the Restricted Stock Units reported in Table II. As reported in this amendment, the reporting person directly beneficially owns 43,956 shares of Common Stock following the reported transaction.

SEC source: 0000899140-24-001286 · form4.xml · derivative · entry 13

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 25,000 shares

Expires 2034-01-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: These options were granted on 01/12/2024. These options vested 1/4 on the date of grant, and, subject to continued employment, will vest 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000899140-24-001286 · form4.xml · derivative · entry 12

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2033-01-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: These options were granted on 1/14/2023. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant and will vest 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000899140-24-001286 · form4.xml · derivative · entry 11

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,033

Underlying: Common Stock · 34,467 shares

Expires 2030-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options were granted on 05/11/2020. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000899140-24-001286 · form4.xml · derivative · entry 10

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,612

Underlying: Common Stock · 9,888 shares

Expires 2030-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options were granted on 05/11/2020. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000899140-24-001286 · form4.xml · derivative · entry 9

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,711

Underlying: Common Stock · 8,169 shares

Expires 2029-01-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted 1/10/2019 and vested as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones.

SEC source: 0000899140-24-001286 · form4.xml · derivative · entry 8

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,997

Underlying: Common Stock · 3 shares

Expires 2028-03-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted 3/19/2018 and vested as follows: 37,200 vested over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vested on the achievement of certain milestones. This option was previously reported as covering 186,000 shares but was adjusted to reflect a reverse stock split that occurred on March 26, 2019.

SEC source: 0000899140-24-001286 · form4.xml · nonDerivative · entry 7

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,397

F1 · security: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · date: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · deemedExecutionDate: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · kind: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · shares: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · price: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · acquired: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · balance_after: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · ownership.direct: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F1 · ownership.nature: This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0000899140-24-001286 · form4.xml · nonDerivative · entry 6

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,424

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899140-24-001286 · form4.xml · nonDerivative · entry 5

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,424

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899140-24-001286 · form4.xml · nonDerivative · entry 4

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,924

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899140-24-001286 · form4.xml · nonDerivative · entry 3

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,457

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899140-24-001286 · form4.xml · nonDerivative · entry 2

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,569

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899140-24-001286 · form4.xml · nonDerivative · entry 1

Hurlburt Elizabeth · CIK 0001735256 · EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899140-24-001352 · form4.xml · nonDerivative · entry 1

Mistry Erin · CIK 0001962774 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,011

SEC source: 0000899140-24-000577 · form4.xml · nonDerivative · entry 1

Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 325,857

SEC source: 0000899140-24-000302 · form4.xml · nonDerivative · entry 1

Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 352,839

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7250 to $3.7500, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

SEC source: 0000899140-24-000324 · form4.xml · derivative · entry 1

Kaplan Myron · CIK 0001672645 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-03-05

F1 · derivative.exercise_date: These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

SEC source: 0000899140-24-000323 · form4.xml · derivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-03-05

F1 · derivative.exercise_date: These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

SEC source: 0000899140-24-000325 · form4.xml · derivative · entry 1

Stewart Robert A · CIK 0001476493 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-03-05

F1 · derivative.exercise_date: These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

SEC source: 0000899140-24-000326 · form4.xml · derivative · entry 1

Lefkowitz Steven W · CIK 0001313149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-03-05

F1 · derivative.exercise_date: These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

SEC source: 0000899140-24-000322 · form4.xml · derivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-03-05

F1 · derivative.exercise_date: These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

SEC source: 0000899140-24-000321 · form4.xml · derivative · entry 1

Duncan Gregory Scott · CIK 0001831127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-03-05

F1 · derivative.exercise_date: These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

SEC source: 0000929638-24-000133 · form4.xml · derivative · entry 3

David Matthew T · CIK 0001811612 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2034-01-11

F2 · derivative.exercise_date: These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000929638-24-000133 · form4.xml · nonDerivative · entry 2

David Matthew T · CIK 0001811612 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,934

SEC source: 0000929638-24-000133 · form4.xml · nonDerivative · entry 1

David Matthew T · CIK 0001811612 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,150

F1 · price: These restricted stock units ("RSUs") were granted on 01/12/2024. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These RSUs vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000929638-24-000134 · form4.xml · derivative · entry 3

Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2034-01-11

F2 · derivative.exercise_date: These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000929638-24-000134 · form4.xml · nonDerivative · entry 2

Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,397

SEC source: 0000929638-24-000134 · form4.xml · nonDerivative · entry 1

Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,000

F1 · price: These restricted stock units ("RSUs") were granted on 01/12/2024. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These RSUs vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000929638-24-000132 · form4.xml · derivative · entry 3

Mistry Erin · CIK 0001962774 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2034-01-11

F2 · derivative.exercise_date: These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000929638-24-000132 · form4.xml · nonDerivative · entry 2

Mistry Erin · CIK 0001962774 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,511

SEC source: 0000929638-24-000132 · form4.xml · nonDerivative · entry 1

Mistry Erin · CIK 0001962774 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,900

F1 · price: These restricted stock units ("RSUs") were granted on 01/12/2024. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These RSUs vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000929638-24-000131 · form4.xml · derivative · entry 3

Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 266,667

Underlying: Common Stock · 266,667 shares

Expires 2034-01-11

F2 · derivative.exercise_date: These options were granted on 01/12/2024. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000929638-24-000131 · form4.xml · nonDerivative · entry 2

Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 339,278

SEC source: 0000929638-24-000131 · form4.xml · nonDerivative · entry 1

Todisco Joseph · CIK 0001774807 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 353,059

F1 · price: These restricted stock units ("RSUs") were granted on 01/12/2024. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These RSUs vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC source: 0000929638-23-003434 · form4.xml · nonDerivative · entry 2

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,250

SEC source: 0000929638-23-003434 · form4.xml · nonDerivative · entry 1

DUNTON ALAN W · CIK 0001304773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,250

SEC source: 0000929638-23-003428 · form4.xml · derivative · entry 2

Zelnick Kaufman Beth · CIK 0002004480 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2033-12-11

F2 · derivative.exercise_date: These options were granted on 12/12/2023. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.